1. Blumberg, A., Marti, H.R.: Adaptation to anemia by decreased oxygen affinity of hemoglobin in patients on dialysis. Kidney Int. 1972; 1: 263–270
2. Backer, A., Reimers, E., Nonnast-Daniel, B., Kühn, K., Koch, K.M., Scigalla, P., Braumann, K.-M., Brunkhorst, R., Boning, D.: Effect of erythropoietin treatment on O2 — affinity and performance in patients with renal anemia. Contr. Nephrol. 1988; 66: 165–175
3. Eckardt, K.-U.: Biology of erythropoietin production. Nephrol. Dial. Transplant. 1995; 10: 1572–1574
4. Goicoechea, M., Vazquez, M.I., Ruiz, M.A., Gomez-Campdera, F., Perez-Garcia, R., Valderrabano, F.: Intravenous calcitriol improves anemia and reduces the need for erythropoietin in haemodialysis patients. Nephron 1998; 78: 23–27
5. Horina, J.H., Schwaberger, G., Brussee, H., Sauseng-Fellegger, G., Holzer, H., Krejs, G.J.: Increased red cell 2,3-diphosphoglycerate levels in haemodialysis patients treated with erythropoietin. Nephrol. Dial. Transplant. 1993; 8: 1219–1222